Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children

Children aged 11 to <24 months received 2 intranasal doses of live attenuated influenza vaccine (LAIV) or placebo, 35 +/- 7 days apart. Dose 1 was administered concomitantly with a combined measles, mumps, and rubella vaccine (Priorix). Seroresponses to measles and mumps were similar between grou...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar:	Lum, L.C.S., Borja-Tabora, C.F., Breiman, R.F., Vesikari, T., Sablan, B.P., Chay, O.M., Tantracheewathorn, T., Schmitt, H.J., Lau, Y.L., Bowonkiratikachorn, P., Tam, J.S., Lee, B.W., Tan, K.K., Pejcz, J., Cha, S., Gutierrez-Brito, M., Kaltenis, P., Vertruyen, A., Czajka, H., Bojarskas, J., Brooks, W.A., Cheng, S.M., Rappaport, R., Baker, S., Gruber, W.C., Forrest, B.D.
Materyal Türü:	Makale
Baskı/Yayın Bilgisi:	Elsevier 2010
Konular:	R Medicine

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children

Benzer Materyaller